BPYPO sets a $0.3985 per share dividend for Q3, yielding 10.47% based on current prices. Brookfield Property Partners L.P. announced a $0.3985 per share quarterly dividend for its 6.375% Series 2 Class A preferred units (BPYPO). The payout equates to a forward yield of 10.
BPYPP declares a $0.4063 per share dividend, yielding 10.05%, payable September 30 to record-date holders. Brookfield Property Partners L.P. announced a $0.4063 per share quarterly dividend for its 6.50% Class A Cumulative Redeemable Perpetual Preferred Units (BPYPP). The
Brookfield Property Preferred L.P. maintains its quarterly dividend at $0.3906 per share, matching previous payouts. Brookfield Property Preferred L.P. CL A CUM PFD 1 (BPYPM) announced a $0.3906 per share quarterly dividend, consistent with its prior distribution. The divi
The mortgage investment firm keeps its monthly payout steady at $0.0775 per share, yielding 11.31%. Atrium Mortgage Investment (AMIVF) announced a $0.0775 per share monthly dividend, unchanged from its previous payout. The dividend yields 11.31% on a forward basis, reflect
Aura Minerals reduces quarterly dividend to $0.72 Aura Minerals has declared a quarterly dividend of $0.72 per share, representing a 7.7% decrease from the prior dividend of $0.78. The forward yield is 4.38%. The dividend is payable on August 28 to shareholders o
The miner boosts its payout to $0.0225 from $0.0150, marking a 50% increase and a forward yield of 0.87%. Equinox Gold raised its quarterly dividend by 50% to $0.0225 per share, up from the prior $0.0150. The move reflects improved cash flow and confidence in sustained ear
The increase marks a 6.3% rise from the previous CAD 0.240 dividend, payable June 3 to shareholders of record. Propel Holdings announced a 6.3% increase in its quarterly dividend to CAD 0.255 per share, up from CAD 0.240 previously. The dividend will be payable on June 3 t
Akebia Therapeutics plans to reset Vafseo pricing after December 2026 TDAPA period following positive VOICE trial results. Akebia Therapeutics announced plans to adjust Vafseo pricing after the December 31, 2026, Transitional Drug Add-on Payment Adjustment (TDAPA) period.
The firm maintains its regular dividend while declaring a $0.05/share special dividend, yielding 13.44% forward. Blue Owl Technology Finance Corp. (OTF) announced a $0.35 per share quarterly dividend, matching its prior payout. The company also declared a $0.05 per share s
Zevra reports $39.7 million in Q2 2026 revenue, driven by $30.2 million from its NPC-focused therapy Miplyffa. Zevra Therapeutics posted Q2 2026 net revenue of $39.7 million, a 53% year-over-year increase. The growth was led by $30.2 million in sales from Miplyffa, its the
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.